Evidence map›Paper›PMID 35405059›Full record

ArticleAMA journal of ethics2022

How Should Representation of Subjects With LEP Become More Equitable in Clinical Trials?

Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A O'Brian, Melissa A Simon

Abstract read
In one paragraph

Article in AMA journal of ethics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Lessons from the field: culturally grounded approaches to recruiting Chinese American immigrant cancer patients to psycho-oncology trials.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Ethical considerations in rapid and novel treatments in psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  15. Automating Clinical Trial Matches Via Natural Language Processing of Synthetic Electronic Health Records and Clinical Trial Eligibility Criteria.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2024
    Article
  16. Strategies to promote language inclusion at 17 CTSA hubs.Journal of clinical and translational science · 2024
    Article
  17. Article
  18. Review
  19. Inclusion of Non-English-Speaking Participants in Studies of Parkinson's Disease: A Call to Action.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jonathan AlhalelFourth-year medical student at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Nicolás FranconeFourth-year medical student the Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Sharon PostScientific editor at the Center for Health Equity Transformation in the Feinberg School of Medicine at Northwestern University in Chicago, Illinois.
Catherine A O'BrianScientific editor at the Center for Health Equity Transformation in the Feinberg School of Medicine at Northwestern University in Chicago, Illinois.
Melissa A SimonThe George H. Gardner, MD, Professor of Clinical Gynecology and vice chair of research in the Department of Obstetrics and Gynecology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.

Funding

Northwestern University Minority Health and Health Disparities Research Training (NU-MHRT)T37MD014248 · NIMHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SIMON, MELISSA A. · 2019 to 2023
$1.4M
NIMHD NIH HHS T37 MD014248
6 · The paper itself

Abstract

Underrepresentation of individuals with limited English proficiency (LEP) who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity. This article suggests strategies for increasing representation of Spanish speakers in clinical rials by emphasizing the importance of early engagement with Spanish language communities, inclusive participant recruitment, and collaborative trial design and implementation. Although investigators and institutions administering government-funded research must meet federal requirements for language assistance, journal editors, peer reviewers, institutional review board members, academic health centers, and all beneficiaries of the biomedical and behavioral research enterprise in the United States must motivate linguistic inclusion.

Indexed as

Clinical Trials as TopicLimited English ProficiencyPatient SelectionCommunication BarriersEthics Committees, ResearchHispanic or LatinoHumansLanguageUnited States

Identifiers

PMID35405059
PMCPMC9052781

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.